Whack, whack whack: it's my winter almanac
Goodbye 2022 … uh oh, here comes 2023
As Moderna announces near-95% efficacy in its new Covid-19 vaccine trial, the focus on distribution has become even more intense.
The latest vaccine from the US company could be ready to ship next year, with Moderna saying it hopes to make 500 million to 1 billion doses in 2021.
It will be easier to distribute than the Pfizer version, as Moderna claims it is more stable, can be kept at between 2C and 8C for up to 30 days and can be stored for six months at -20C. Pfizer’s vaccine requires ultracold freezing at between -70C and -80C.
The Logistics & Supply Chain Management Society and IDC have written a research paper advocating the use of a Vaccine Distribution Ecosystem in a public-private partnership that “orchestrates the private and public networks to ensure that populations are effectively inoculated”.
Etail by air – here to stay or on a short shelf life?
HMM sees opportunities in Hapag-Lloyd’s exit from THE Alliance
The rise and rise of China's ecommerce platforms
Increasing scrutiny could stall rise of ecommerce platforms, as TikTok faces US ban
Legal battle heats up over 'unseaworthy' and 'reckless' MV Dali
DSV chief reticent on Schenker: the focus on growing market share
Another strong month for US ports as container flows continue to rise
MSC redeploys 'Israel-linked' box ships away from Persian Gulf
Alex Lennane
email: [email protected]
mobile: +44 7879 334 389
During August 2023, please contact
Alex Whiteman
email: [email protected]
Alessandro Pasetti
email: [email protected]
mobile: +44 7402 255 512
Comment on this article